» Articles » PMID: 8994297

Clinical Pathologic Changes in Two Marmosets with Wasting Syndrome

Overview
Journal Toxicol Pathol
Publisher Sage Publications
Date 1996 Nov 1
PMID 8994297
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Two sexually mature marmosets (Callithrix jacchus) showing clinical signs similar to those seen in wasting marmoset syndrome (weight loss, decreased muscle mass, and alopecia) were evaluated for clinical and anatomic pathologic changes. The most prominent clinical pathologic alterations included macrocytic normochromic anemia, hypoproteinemia, hypoalbuminemia, elevated serum aspartate aminotransferase and alkaline phosphatase levels, and previously unreported changes of thrombocytosis. The principal gross and histopathologic finding was chronic colitis, which appeared to be the most important contributing factor to the development of wasting syndrome in these marmosets.

Citing Articles

The Common Marmoset-Biomedical Research Animal Model Applications and Common Spontaneous Diseases.

Han H, Powers S, Gabrielson K Toxicol Pathol. 2022; 50(5):628-637.

PMID: 35535728 PMC: 9310150. DOI: 10.1177/01926233221095449.


Immunohistochemical Characterization of a Duodenal Adenocarcinoma with Pulmonary, Hepatic and Parapatellar Metastases in a Common Marmoset (Callithrixjacchus).

Peterson C, Plunkard J, Johanson A, Izzi J, Gabrielson K J Comp Pathol. 2021; 189:1-7.

PMID: 34886977 PMC: 8669625. DOI: 10.1016/j.jcpa.2021.09.002.


Whole blood transfusion in common marmosets: a clinical evaluation.

Yurimoto T, Mineshige T, Shinohara H, Inoue T, Sasaki E Exp Anim. 2021; 71(2):131-138.

PMID: 34789617 PMC: 9130032. DOI: 10.1538/expanim.21-0134.


Clinical Management of Gastrointestinal Disease in the Common Marmoset (Callithrix jacchus).

Fitz C, Goodroe A, Wierenga L, Mejia A, Simmons H ILAR J. 2021; 61(2-3):199-217.

PMID: 33989417 PMC: 9214573. DOI: 10.1093/ilar/ilab012.


Preclinical Marmoset Model for Targeting Chronic Inflammation as a Strategy to Prevent Alzheimer's Disease.

Philippens I, Langermans J Vaccines (Basel). 2021; 9(4).

PMID: 33920929 PMC: 8071309. DOI: 10.3390/vaccines9040388.